Rexnord Corporation (RXN) Stock Competitors & Peer Comparison
See (RXN) competitors and their performances in Stock Market.
Peer Comparison Table: Regulated Water Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RXN | $64.95 | +0.90% | 11.4B | N/A | N/A | +0.54% |
| AWK | $131.53 | -1.59% | 25.7B | 23.19 | $5.67 | +2.58% |
| SBS | $5.68 | -1.22% | 19.4B | 5.56 | $1.02 | +2.36% |
| WTRG | $38.92 | -1.19% | 11B | 19.36 | $2.01 | +3.53% |
| AWR | $86.60 | -2.04% | 3.4B | 25.25 | $3.43 | +2.32% |
| CWT | $50.62 | -1.48% | 3B | 25.31 | $2.00 | +2.51% |
| HTO | $64.02 | -0.77% | 2.2B | 21.48 | $2.98 | +2.70% |
| SJW | $54.86 | -0.67% | 1.9B | 18.29 | $3.00 | +1.60% |
| MSEX | $56.01 | -1.37% | 1B | 23.34 | $2.40 | +2.54% |
| YORW | $30.66 | -1.92% | 497M | 20.86 | $1.47 | +2.95% |
Stock Comparison
RXN vs AWK Comparison July 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, AWK has a market cap of 25.7B. Regarding current trading prices, RXN is priced at $64.95, while AWK trades at $131.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas AWK's P/E ratio is 23.19. In terms of profitability, RXN's ROE is +0.13%, compared to AWK's ROE of +0.10%. Regarding short-term risk, RXN is more volatile compared to AWK. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check AWK's competition here
RXN vs SBS Comparison July 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, SBS has a market cap of 19.4B. Regarding current trading prices, RXN is priced at $64.95, while SBS trades at $5.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas SBS's P/E ratio is 5.56. In terms of profitability, RXN's ROE is +0.13%, compared to SBS's ROE of +0.20%. Regarding short-term risk, RXN is less volatile compared to SBS. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check SBS's competition here
RXN vs WTRG Comparison July 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, WTRG has a market cap of 11B. Regarding current trading prices, RXN is priced at $64.95, while WTRG trades at $38.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas WTRG's P/E ratio is 19.36. In terms of profitability, RXN's ROE is +0.13%, compared to WTRG's ROE of +0.08%. Regarding short-term risk, RXN is more volatile compared to WTRG. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check WTRG's competition here
RXN vs AWR Comparison July 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, AWR has a market cap of 3.4B. Regarding current trading prices, RXN is priced at $64.95, while AWR trades at $86.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas AWR's P/E ratio is 25.25. In terms of profitability, RXN's ROE is +0.13%, compared to AWR's ROE of +0.13%. Regarding short-term risk, RXN is more volatile compared to AWR. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check AWR's competition here
RXN vs CWT Comparison July 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, CWT has a market cap of 3B. Regarding current trading prices, RXN is priced at $64.95, while CWT trades at $50.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas CWT's P/E ratio is 25.31. In terms of profitability, RXN's ROE is +0.13%, compared to CWT's ROE of +0.07%. Regarding short-term risk, RXN is more volatile compared to CWT. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check CWT's competition here
RXN vs HTO Comparison July 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, HTO has a market cap of 2.2B. Regarding current trading prices, RXN is priced at $64.95, while HTO trades at $64.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas HTO's P/E ratio is 21.48. In terms of profitability, RXN's ROE is +0.13%, compared to HTO's ROE of +0.07%. Regarding short-term risk, RXN is more volatile compared to HTO. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check HTO's competition here
RXN vs SJW Comparison July 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, SJW has a market cap of 1.9B. Regarding current trading prices, RXN is priced at $64.95, while SJW trades at $54.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas SJW's P/E ratio is 18.29. In terms of profitability, RXN's ROE is +0.13%, compared to SJW's ROE of +0.07%. Regarding short-term risk, RXN is less volatile compared to SJW. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check SJW's competition here
RXN vs MSEX Comparison July 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, MSEX has a market cap of 1B. Regarding current trading prices, RXN is priced at $64.95, while MSEX trades at $56.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas MSEX's P/E ratio is 23.34. In terms of profitability, RXN's ROE is +0.13%, compared to MSEX's ROE of +0.09%. Regarding short-term risk, RXN is less volatile compared to MSEX. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check MSEX's competition here
RXN vs YORW Comparison July 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, YORW has a market cap of 497M. Regarding current trading prices, RXN is priced at $64.95, while YORW trades at $30.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas YORW's P/E ratio is 20.86. In terms of profitability, RXN's ROE is +0.13%, compared to YORW's ROE of +0.09%. Regarding short-term risk, RXN is more volatile compared to YORW. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check YORW's competition here
RXN vs CWCO Comparison July 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, CWCO has a market cap of 461.4M. Regarding current trading prices, RXN is priced at $64.95, while CWCO trades at $28.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas CWCO's P/E ratio is 26.46. In terms of profitability, RXN's ROE is +0.13%, compared to CWCO's ROE of +0.08%. Regarding short-term risk, RXN is less volatile compared to CWCO. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check CWCO's competition here
RXN vs ARTNA Comparison July 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, ARTNA has a market cap of 343.7M. Regarding current trading prices, RXN is priced at $64.95, while ARTNA trades at $33.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas ARTNA's P/E ratio is 14.73. In terms of profitability, RXN's ROE is +0.13%, compared to ARTNA's ROE of +0.09%. Regarding short-term risk, RXN is less volatile compared to ARTNA. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check ARTNA's competition here
RXN vs VWTR Comparison July 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, VWTR has a market cap of 288.2M. Regarding current trading prices, RXN is priced at $64.95, while VWTR trades at $15.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas VWTR's P/E ratio is 9.29. In terms of profitability, RXN's ROE is +0.13%, compared to VWTR's ROE of +0.17%. Regarding short-term risk, RXN is more volatile compared to VWTR. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check VWTR's competition here
RXN vs CDZIP Comparison July 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, CDZIP has a market cap of 284.2M. Regarding current trading prices, RXN is priced at $64.95, while CDZIP trades at $22.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas CDZIP's P/E ratio is -50.37. In terms of profitability, RXN's ROE is +0.13%, compared to CDZIP's ROE of -1.30%. Regarding short-term risk, RXN is more volatile compared to CDZIP. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check CDZIP's competition here
RXN vs CDZI Comparison July 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, CDZI has a market cap of 280.8M. Regarding current trading prices, RXN is priced at $64.95, while CDZI trades at $3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas CDZI's P/E ratio is -7.26. In terms of profitability, RXN's ROE is +0.13%, compared to CDZI's ROE of -1.30%. Regarding short-term risk, RXN is less volatile compared to CDZI. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check CDZI's competition here
RXN vs PCYO Comparison July 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, PCYO has a market cap of 255.9M. Regarding current trading prices, RXN is priced at $64.95, while PCYO trades at $10.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas PCYO's P/E ratio is 17.41. In terms of profitability, RXN's ROE is +0.13%, compared to PCYO's ROE of +0.10%. Regarding short-term risk, RXN is less volatile compared to PCYO. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check PCYO's competition here
RXN vs GWRS Comparison July 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, GWRS has a market cap of 203.9M. Regarding current trading prices, RXN is priced at $64.95, while GWRS trades at $7.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas GWRS's P/E ratio is 64.45. In terms of profitability, RXN's ROE is +0.13%, compared to GWRS's ROE of +0.02%. Regarding short-term risk, RXN is less volatile compared to GWRS. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check GWRS's competition here
RXN vs WTRU Comparison July 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, WTRU has a market cap of 0. Regarding current trading prices, RXN is priced at $64.95, while WTRU trades at $53.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas WTRU's P/E ratio is 60.58. In terms of profitability, RXN's ROE is +0.13%, compared to WTRU's ROE of +0.08%. Regarding short-term risk, RXN is less volatile compared to WTRU. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check WTRU's competition here